|
The American
Cancer Society has updated their recommendations for screening
for colorectal cancer to advise that although a combination of
fecal occult blood test and sigmoidoscopy is preferable, one of
these tests is far better than none.
These guidelines
appear in the Cancer Journal for Clinicians in response to the
concerns of physicians.
"Many primary
care physicians and others were telling us that they were not
prepared to offer sigmoidoscopy," notes Robert Smith, of the ACS.
"We know that fecal occult blood testing (FOBT) alone is effective.
We know that flexible sigmoidoscopy alone is effective. We believe
that the data show that the combined testing is more effective.
But the most important thing that anyone, provider or patient,
can do now is at least do something," the report concluded.
Other
sources: The American Cancer Society, Cancer Journal for Clinicians
|